EUVIMEDEUVIMED entdecken
Crossref

Combination of Targeted Therapies for Colorectal Cancer Treatment

Elodie Péraudeau, Brigitte Renoux, Sheik Emambux, Pauline Poinot iD, Rémi Châtre, Fabien Thoreau, Benjamin Riss Yaw, David Tougeron, Jonathan Clarhaut, Sébastien Papot iD

Molecular Pharmaceutics · 04.09.2023 · 20 (9) · 4537-4545

DOI: 10.1021/acs.molpharmaceut.3c00224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 14.08.2023. Verfasst von Elodie Péraudeau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Equipe Labellisée Ligue Contre le Cancer, Université de Poitiers, UMR CNRS 7285, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 4 r…. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Immunoconjugates, Colorectal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Ligue Contre le Cancer, Soci?t? Nationale Fran?aise de Gastro-Ent?rologie, Conseil R?gional Aquitaine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The design of innovative therapeutic strategies enabling the selective destruction of tumor cells while sparing healthy tissues remains highly challenging in cancer therapy. Here, we show that the combination of two targeted therapies, including bevacizumab (Bev), and a β-glucuronidase-responsive albumin-binding prodrug of monomethyl auristatin E (MMAE), is efficient for the treatment of colorectal cancer implanted in mice. This combined therapy produces a therapeutic activity superior to that of the association of FOLFOX and Bev currently used to treat patients with this pathology. The increased anticancer efficacy is due to either a synergistic or an additive effect between Bev and MMAE selectively released from the glucuronide prodrug in the tumor microenvironment. Since numerous drug delivery systems such as antibody-drug conjugates employ MMAE as a cytotoxic payload, this finding may be of great interest for improving their therapeutic index by combining them with Bev, particularly for the therapy of colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAntineoplastic AgentsImmunoconjugatesColorectal NeoplasmsAnimalsMiceMolecular Targeted TherapyCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

antiangiogenic therapycolon cancertargeted polytherapytumor microenvironmentβ-glucuronidase-responsive albumin-binding prodrug

Substanzen

ProdrugsAntineoplastic AgentsImmunoconjugates

Autor:innen und Institutionen

  • Equipe Labellisée Ligue Contre le Cancer, Université de Poitiers, UMR CNRS 7285, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 4 rue Michel-Brunet, TSA 51106, 86073 Poitiers, Cedex 9, France.
  • CHU de Poitiers, 86021 Poitiers, France.
  • Department of Medical Oncology, Poitiers University Hospital, 86021 Poitiers, France.
  • Department of Gastroenterology and Hepatology, Poitiers University Hospital, 86021 Poitiers, France.

ORCID-Profile: Pauline Poinot, Sébastien Papot

Förderung

  • Ligue Contre le Cancer
  • Soci?t? Nationale Fran?aise de Gastro-Ent?rologie
  • Conseil R?gional Aquitaine

Zitieren

APA

Péraudeau, E., Renoux, B., Emambux, S., Poinot, P., Châtre, R., Thoreau, F., Riss Yaw, B., Tougeron, D., Clarhaut, J., & Papot, S. (2023). Combination of Targeted Therapies for Colorectal Cancer Treatment. Molecular Pharmaceutics, 20(9), 4537-4545. https://doi.org/10.1021/acs.molpharmaceut.3c00224

Vancouver

Péraudeau E, Renoux B, Emambux S, Poinot P, Châtre R, Thoreau F, et al. Combination of Targeted Therapies for Colorectal Cancer Treatment. Molecular Pharmaceutics. 2023;20(9):4537-4545. doi:10.1021/acs.molpharmaceut.3c00224

BibTeX
@article{Praudeau2023,
  author = {Péraudeau, Elodie and Renoux, Brigitte and Emambux, Sheik and Poinot, Pauline and Châtre, Rémi and Thoreau, Fabien and Riss Yaw, Benjamin and Tougeron, David and Clarhaut, Jonathan and Papot, Sébastien},
  title = {Combination of Targeted Therapies for Colorectal Cancer Treatment},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {9},
  pages = {4537--4545},
  doi = {10.1021/acs.molpharmaceut.3c00224}
}
Kostenlos starten →